BNP PARIBAS FINANCIAL MARKETS - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$110,919
+42.8%
28,152
+285.4%
0.00%
Q2 2023$77,652
-13.5%
7,305
-32.2%
0.00%
Q1 2023$89,797
-69.2%
10,780
-65.8%
0.00%
Q4 2022$291,336
-99.9%
31,564
+84.5%
0.00%
Q3 2022$219,718,000
+15.7%
17,112
+19.0%
0.00%
Q2 2022$189,907,000
+448.4%
14,376
+773.9%
0.00%
Q1 2022$34,627,000
-64.5%
1,645
-59.6%
0.00%
Q4 2021$97,663,000
-76.3%
4,071
-74.9%
0.00%
-100.0%
Q3 2021$412,179,000
+1624.7%
16,202
+2182.0%
0.00%
Q2 2021$23,899,000
-85.3%
710
-83.0%
0.00%
Q1 2021$162,623,000
+34.5%
4,187
+114.5%
0.00%
Q4 2020$120,887,000
+24.6%
1,952
-32.6%
0.00%
Q3 2020$96,987,000
+469.2%
2,896
+305.0%
0.00%
Q2 2020$17,038,000
-85.7%
715
-86.3%
0.00%
Q1 2020$119,538,000
+234.5%
5,220
+313.6%
0.00%
Q4 2019$35,740,000
+43.6%
1,262
+9.0%
0.00%
Q3 2019$24,885,0001,1580.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$7,551,0001.86%
RTW INVESTMENTS, LP 3,644,248$92,710,0001.40%
Cormorant Asset Management, LP 1,278,276$32,519,0001.32%
Redmile Group, LLC 2,381,958$60,597,0001.06%
HighVista Strategies LLC 47,594$1,211,0000.80%
Birchview Capital, LP 15,000$382,0000.26%
GILDER GAGNON HOWE & CO LLC 1,123,355$28,578,0000.15%
Artal Group S.A. 250,000$6,360,0000.14%
Tekla Capital Management LLC 99,263$2,525,0000.08%
Casdin Capital, LLC 120,000$3,053,0000.08%
View complete list of STOKE THERAPEUTICS INC shareholders